Treatment recommendations in Primary Ciliary Dyskinesia

Deepika Polineni, Stephanie Davis, Sharon D. Dell

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Primary Ciliary Dyskinesia (PCD) is a rare heterogenic disorder leading to significant respiratory morbidity. Health-care providers who treat PCD must familiarize themselves with recommended treatment strategies. However, most of the treatments recommended in PCD have been extrapolated from cystic fibrosis (CF) and non-CF bronchiectasis literature. Mainstays of therapy are reviewed in detail, and should include at a minimum: regular airway clearance, routine microbiological surveillance, antibiotic treatment for pulmonary exacerbation, and health vaccinations. This review summarizes both medical and surgical pulmonary treatment considerations, as well as recommendations for the integration of non-pulmonary subspecialty care in the management of PCD.

Original languageEnglish (US)
JournalPaediatric Respiratory Reviews
DOIs
StateAccepted/In press - 2015

Fingerprint

Kartagener Syndrome
Therapeutics
Lung
Bronchiectasis
Cystic Fibrosis
Health Personnel
Vaccination
Fibrosis
Anti-Bacterial Agents
Morbidity
Health

Keywords

  • Bronchiectasis
  • Mucociliary clearance
  • Primary ciliary dyskinesia
  • Treatments

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Treatment recommendations in Primary Ciliary Dyskinesia. / Polineni, Deepika; Davis, Stephanie; Dell, Sharon D.

In: Paediatric Respiratory Reviews, 2015.

Research output: Contribution to journalArticle

@article{729fd738085f4149b8202d99ac70ff2d,
title = "Treatment recommendations in Primary Ciliary Dyskinesia",
abstract = "Primary Ciliary Dyskinesia (PCD) is a rare heterogenic disorder leading to significant respiratory morbidity. Health-care providers who treat PCD must familiarize themselves with recommended treatment strategies. However, most of the treatments recommended in PCD have been extrapolated from cystic fibrosis (CF) and non-CF bronchiectasis literature. Mainstays of therapy are reviewed in detail, and should include at a minimum: regular airway clearance, routine microbiological surveillance, antibiotic treatment for pulmonary exacerbation, and health vaccinations. This review summarizes both medical and surgical pulmonary treatment considerations, as well as recommendations for the integration of non-pulmonary subspecialty care in the management of PCD.",
keywords = "Bronchiectasis, Mucociliary clearance, Primary ciliary dyskinesia, Treatments",
author = "Deepika Polineni and Stephanie Davis and Dell, {Sharon D.}",
year = "2015",
doi = "10.1016/j.prrv.2015.10.002",
language = "English (US)",
journal = "Paediatric Respiratory Reviews",
issn = "1526-0542",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Treatment recommendations in Primary Ciliary Dyskinesia

AU - Polineni, Deepika

AU - Davis, Stephanie

AU - Dell, Sharon D.

PY - 2015

Y1 - 2015

N2 - Primary Ciliary Dyskinesia (PCD) is a rare heterogenic disorder leading to significant respiratory morbidity. Health-care providers who treat PCD must familiarize themselves with recommended treatment strategies. However, most of the treatments recommended in PCD have been extrapolated from cystic fibrosis (CF) and non-CF bronchiectasis literature. Mainstays of therapy are reviewed in detail, and should include at a minimum: regular airway clearance, routine microbiological surveillance, antibiotic treatment for pulmonary exacerbation, and health vaccinations. This review summarizes both medical and surgical pulmonary treatment considerations, as well as recommendations for the integration of non-pulmonary subspecialty care in the management of PCD.

AB - Primary Ciliary Dyskinesia (PCD) is a rare heterogenic disorder leading to significant respiratory morbidity. Health-care providers who treat PCD must familiarize themselves with recommended treatment strategies. However, most of the treatments recommended in PCD have been extrapolated from cystic fibrosis (CF) and non-CF bronchiectasis literature. Mainstays of therapy are reviewed in detail, and should include at a minimum: regular airway clearance, routine microbiological surveillance, antibiotic treatment for pulmonary exacerbation, and health vaccinations. This review summarizes both medical and surgical pulmonary treatment considerations, as well as recommendations for the integration of non-pulmonary subspecialty care in the management of PCD.

KW - Bronchiectasis

KW - Mucociliary clearance

KW - Primary ciliary dyskinesia

KW - Treatments

UR - http://www.scopus.com/inward/record.url?scp=84949009391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949009391&partnerID=8YFLogxK

U2 - 10.1016/j.prrv.2015.10.002

DO - 10.1016/j.prrv.2015.10.002

M3 - Article

C2 - 26586601

AN - SCOPUS:84949009391

JO - Paediatric Respiratory Reviews

JF - Paediatric Respiratory Reviews

SN - 1526-0542

ER -